Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1117-37-9 | MDL No. : | MFCD00144269 |
Formula : | C7H13NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MVUMJYQUKKUOHO-AATRIKPKSA-N |
M.W : | 143.18 | Pubchem ID : | 5369162 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.57 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 39.47 |
TPSA : | 29.54 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.57 cm/s |
Log Po/w (iLOGP) : | 1.9 |
Log Po/w (XLOGP3) : | 0.85 |
Log Po/w (WLOGP) : | 0.62 |
Log Po/w (MLOGP) : | 0.64 |
Log Po/w (SILICOS-IT) : | 0.19 |
Consensus Log Po/w : | 0.84 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.0 |
Solubility : | 14.3 mg/ml ; 0.1 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.05 |
Solubility : | 12.7 mg/ml ; 0.0884 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.54 |
Solubility : | 41.5 mg/ml ; 0.29 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.23 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P272-P280-P302+P352-P312-P333+P313-P362+P364-P501 | UN#: | N/A |
Hazard Statements: | H302-H317 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 13412-12-9 ]
Methyl 3-(methylamino)but-2-enoate
Similarity: 0.71
[ 2439-35-2 ]
2-(Dimethylamino)ethyl acrylate
Similarity: 0.68
[ 70526-06-6 ]
(Z)-Ethyl 3-(pyrrolidin-1-yl)but-2-enoate
Similarity: 0.67
[ 54716-02-8 ]
(E)-Ethyl 3-(pyrrolidin-1-yl)but-2-enoate
Similarity: 0.67
[ 13412-12-9 ]
Methyl 3-(methylamino)but-2-enoate
Similarity: 0.71
[ 2439-35-2 ]
2-(Dimethylamino)ethyl acrylate
Similarity: 0.68
[ 2459-05-4 ]
(E)-4-Ethoxy-4-oxobut-2-enoic acid
Similarity: 0.67
[ 23652-67-7 ]
(E)-Ethyl 3-acetamidobut-2-enoate
Similarity: 0.64
[ 13412-12-9 ]
Methyl 3-(methylamino)but-2-enoate
Similarity: 0.71
[ 2439-35-2 ]
2-(Dimethylamino)ethyl acrylate
Similarity: 0.68
[ 70526-06-6 ]
(Z)-Ethyl 3-(pyrrolidin-1-yl)but-2-enoate
Similarity: 0.67
[ 54716-02-8 ]
(E)-Ethyl 3-(pyrrolidin-1-yl)but-2-enoate
Similarity: 0.67
[ 13412-12-9 ]
Methyl 3-(methylamino)but-2-enoate
Similarity: 0.71
[ 2439-35-2 ]
2-(Dimethylamino)ethyl acrylate
Similarity: 0.68
[ 23652-67-7 ]
(E)-Ethyl 3-acetamidobut-2-enoate
Similarity: 0.64
[ 203186-56-5 ]
(E)-Methyl 2-((dimethylamino)methylene)-3-oxobutanoate
Similarity: 0.60